Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of fexofenadine in patients with irritable bowel syndrome
IRCT20160813029327N20Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of fexofenadine in irritable bowel syndrome (IBS), sponsored by Islamic Azad University. Started Apr 2022; status: completed.
02
Drugs
fexofenadine
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on IRCT20160813029327N20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160813029327N20.